AVE avecho biotechnology limited

the sce report, page-4

  1. 6,655 Posts.
    Top of the morning bio and welcome to the madhouse.

    I agree in the main that the SCE report is very good with one caveat.

    Look I'm no genius, as is evident by my previous posts,but for the life of me I don't understand the inclusion of a cap raising assumption at 11c per share and the deafening silence from the company on that point.

    I am interested in your point of view on that as you have obviously taken time to study the report in detail.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.5¢
Change
0.000(0.00%)
Mkt cap ! $14.28M
Open High Low Value Volume
0.5¢ 0.5¢ 0.4¢ $26.59K 6.419M

Buyers (Bids)

No. Vol. Price($)
13 7711400 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 20942354 23
View Market Depth
Last trade - 15.22pm 16/07/2025 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.